Trudy M. Forte - Berkeley CA, US Mina Nikanjam - Richmond CA, US
Assignee:
LAWRENCE BERKELEY NATIONAL LABORATORY - BERKELEY CA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - OAKLAND CA CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND - OAKLAND CA
International Classification:
A61K 38/16 A61K 51/00 A61P 35/00
US Classification:
424 129, 514 12
Abstract:
The present invention provides a synthetic LDL nanoparticle comprising a lipid moiety and a synthetic chimeric peptide so s to be capable of binding the LDL receptor. The synthetic LDL nanoparticle of the present invention is capable of c incorporating and targeting therapeutics for diseases associated with the expression of the LDL receptor. The invention further provides methods of using such synthetic LDL nanoparticles.
Medicine Doctors
Dr. Mina Nikanjam, Santa Clara CA - MD (Doctor of Medicine)